CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma

Allergy. 2022 Nov;77(11):3463-3466. doi: 10.1111/all.15465. Epub 2022 Aug 12.

Authors

Sharon Mumby¹, Nazanin Zounemat Kermani², James P Garnett³, Stelios Pavlidis², Susan J Wilson⁴, Peter J Howarth⁴, Matthew J Thomas³, Ian M Adcock¹, Carlos López-García¹

Affiliations

¹ Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
² Department of Computing, Data Science Institute, Imperial College London, London, UK.
³ Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH and Co KG Biberach, Biberach, Germany.
⁴ Faculty of Medicine, University of Southampton, Southampton, UK.

PMID: 35916059
DOI: 10.1111/all.15465

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Asthma* / genetics
Carcinoembryonic Antigen
GPI-Linked Proteins
Humans
Interleukin-13* / genetics

Substances

Interleukin-13
CEACAM5 protein, human
Carcinoembryonic Antigen
GPI-Linked Proteins

Grants and funding

CRUK_/Cancer Research UK/United Kingdom